Sialyl Stage-Specific Embryonic Antigen-1: A Useful Marker for Differentiating the Etiology of Pleural Effusion

Chest

Volumn 114, Issue 6, 1998, Pages 1542-1545

  Lee, Yu Chin ^a,c   Chern, Jia Haur ^b,c   Lai, Shinn Liang ^a,c   Perng, Reury Perng ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Taipei Municipal Chung Hsiao Hospital   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Adenocarcinoma; Lung neoplasms; Pleural effusion; Sialyl SSEA 1; Tumor markers

Indexed keywords

CD15 ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; LUNG TUMOR; MALE; MIDDLE AGED; PLEURA EFFUSION; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD15; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; SENSITIVITY AND SPECIFICITY;

EID: 0032252351     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.6.1542     Document Type: Article

References (25)

1. Bartter T, Santarelli R, Akers SM, et al. The evaluation of pleural effusion. Chest 1994; 106:1209-1214
2. Solter D, Knowles BB. Monoclonal antibody defining a stage specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sei USA 1978; 75:5565-5567
3. Kannagi R, Nudelman E, Hakomori S. Possible role of ceramide in defining structure and function of membrane glycolipids. Proc Natl Acad Sci USA 1982; 79:3470-3474
4. Kannagi R, Nudelman E, Levery SB, et al. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen, SSEA-1. J Biol Chem 1982; 257:14865-14874
5. 3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res 1985; 45:3711-3717
6. Kannagi R, Fukushi Y, Tachikawa T, et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res 1986; 46:2619-2626
7. Itai S, Nishikata J, Takahashi N, et al. Differentiation-dependent expression of i and Sialyl i antigens in the developing lung of human embryos and in lung cancers. Cancer Res 1990; 50:7603-7611
8. Lee YC, Yang MH, Huang MH, et al. Serum sialyl stage-specific embryonic antigen levels in adenocarcinoma of the lung. J Formos Med Assoc 1992; 91:760-763
9. Light RW. Clinical manifestations and useful tests. In: Pleural diseases. 3rd ed. Baltimore: Williams & Wilkins, 1995; 36-74
10. Light RW. Parapneumonic effusions and empyema. In: Pleural diseases. 3rd ed. Baltimore: Williams & Wilkins, 1995; 129-153
11. Imura H, Endo J, Ohkura H, et al. Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen. Jpn J Cancer Chemother 1987; 14:1315-1321
12. Huang LC, Brockhaus M, Magnani JL, et al. Many monoclonal antibodies with an apparent specificity for certain lung cancers are directed against a sugar sequence found in lacto-N-fucopentaose III. Arch Biochem Biophys 1983; 220: 318-320
13. Fukushi Y, Hakomori S, Nudelman E, et al. Novel fucolipids accumulating in human adenocarcinoma: II. selective isolation of hybridoma antibodies that differentially recognize mono-, di- and trifucosylated type 2 chain. J Biol Chem 1984; 259:4681-4685
14. 3Fuc2nLc6). J Biol Chem 1984; 259:10511-10517
15. Spitalnik SL, Spitalnik PF, Dubois C, et al. Glycolipid antigen expression in human lung cancer. Cancer Res 1986; 46:4751-4755
16. Hakomori S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem 1981; 50:733-764
17. Hakomori S, Kannagi R. Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst 1983; 71:231-251
18. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989; 52:257-331
19. Miyake M, Zenita K, Tanaka O, et al. Stage-specific expression of SSEA-1-related antigens in the developing lung of human embryos and its relation to the distribution to these antigens in lung cancers. Cancer Res 1988; 48:7150-7158
20. 2-microglobulin. Cancer 1982; 50:1783-1788
21. Yinnon A, Konijn AM, Link G, et al. Diagnostic value of ferritin in malignant pleural and peritoneal effusions. Cancer 1988; 62:2564-2568
22. Klockars M, Pettersson T, Froseth B, et al. Concentration of tumor-associated trypsin inhibitor (TATI) in pleural effusions. Chest 1990; 98:1159-1164
23. Hara N, Abe M, Inuzuka S, et al. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions. Chest 1992; 102:1060-1064
24. Imecik O, Ozer F. Diagnostic value of sialic acid in malignant pleural effusions. Chest 1992; 102:1819-1822
25. Chang SC, Hsu YT, Chen YC, et al. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions. Arch Intern Med 1994; 154:1097-1101